Reference health
Micronization of atorvastatin calcium by antisolvent precipitation process
34/34 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
The 34 checked references that resolve
resolves10.1016/j.ijpharm.2003.09.044
Feasibility of preparing nanodrugs by high-gravity reactive precipitation
resolves10.1016/j.ijpharm.2006.09.022
Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation
resolves10.1016/0009-2509(91)80035-W
Fundamentals of crystallization: Kinetic effects on particle size distributions and morphology
resolves10.1016/j.ejpb.2006.02.004
Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique
resolves10.1016/j.ejpb.2006.10.005
Correlation between digestion of the lipid phase of smedds and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from smedds
resolves10.1016/j.ejps.2008.05.005
Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781
resolves10.1016/j.ejpb.2006.05.008
Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base
resolves10.1016/j.ijpharm.2008.04.006
Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process
resolves10.1016/j.ejpb.2008.01.007
Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process
resolves10.1016/S0378-5173(00)00626-8
Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation
resolves10.1016/j.powtec.2008.04.039
Novel mechanistic description of the water granulation process for hydrophilic polymers
resolves10.1016/S0939-6411(00)00076-X
Improving drug solubility for oral delivery using solid dispersions
resolves10.1016/j.ijpharm.2007.04.025
Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method
resolves10.1016/S0928-0987(02)00251-8
Nanosizing: a formulation approach for poorly-water-soluble compounds
resolves10.1016/j.ijpharm.2004.09.007
Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes
resolves10.1016/S0040-4039(02)00175-2
An improved synthesis of 1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate, a key intermediate for atorvastatin synthesis
resolves10.1016/S0378-5173(03)00299-0
Formation and stabilisation of triclosan colloidal suspensions using supersaturated systems
resolves10.1016/S0378-5173(01)00673-1
Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers
resolves10.1016/S0378-5173(00)00610-4
Crystallization of hydrocortisone acetate: influence of polymers
resolves10.1002/jps.10274
Micronization of Anti-Inflammatory Drugs for Pulmonary Delivery by a Controlled Crystallization Process
resolves10.1016/j.supflu.2008.04.010
Supercritical fluid assisted production of HPMC composite microparticles
resolves10.1016/j.supflu.2006.07.003
Controlled submicro particle formation of ampicillin by supercritical antisolvent precipitation
resolves10.1021/op9701088
In Pursuit of Higher Purity: Use of <sup>13</sup>C NMR and <sup>13</sup>C-Enriched Substrates To Trace Impurity Generation and Removal in the Synthesis of Atorvastatin
resolves10.1021/ie0615537
Preparation of Ultrafine Beclomethasone Dipropionate Drug Powder by Antisolvent Precipitation
resolves10.1016/j.vibspec.2003.11.004
An innovative design of compaction cell for in situ FT-IR imaging of tablet dissolution
resolves10.1016/j.ijpharm.2005.05.017
Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process
resolves10.1016/j.ijpharm.2006.05.048
Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants
resolves10.1021/ie070498e
Controlled Liquid Antisolvent Precipitation of Hydrophobic Pharmaceutical Nanoparticles in a Microchannel Reactor
resolves10.1016/j.ijpharm.2005.06.005
Preparation and characterization of uniform nanosized cephradine by combination of reactive precipitation and liquid anti-solvent precipitation under high gravity environment
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.ijpharm.2009.02.015"><img src="https://citestamp.com/citestamped/10.1016/j.ijpharm.2009.02.015/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.ijpharm.2009.02.015)